Supplementary Tables S1-S15 from Tracing Founder Mutations in Circulating and Tissue-Resident Follicular Lymphoma Precursors

Supplementary Table S1. Patient and control clinical characteristics Supplementary Table S2. Sequencing metrics for FL cases & controls Supplementary Table S3. Identified mutations in EPIC FL pre-diagnostic samples Supplementary Table S4. Identified mutations in control samples Supplementary Table S5. Statistical significance for detection in prediagnostic samples with paired tumor biopsy Supplementary Table S6. Identified mutations in FL tumors with detection in paired prediagnostic samples Supplementary Table S7. Paired tumor cohort histology & sample characteristics Supplementary Table S8. Identified mutations in paired biopsy samples Supplementary Table S9. Clonal VDJ rearrangements in paired biopsies Supplementary Table S10. Concordance analysis of paired biopsy samples Supplementary Table S11. Patient characteristics, marrow and sorting studies Supplementary Table S12. DNA and sequencing metrics for marrow and sorting studies Supplementary Table S13. Monoclonal antibodies and manufacturers Supplementary Table S14. Mutations detected in marrow and sorting studies Supplementary Table S15. Genes fully or partially covered in lymphoma-focused CAPP-Seq selector